Dirk Thye
Chief Executive Officer at Quince Therapeutics.
Earliest Form D on file: Jun 2026
2 filings at 1 company
Quince Therapeutics
Biotech, South San Francisco CA
Chief Executive Officer · signer
- Signed
- Named
- Size is amount sold, up to $30M
Filings
2- Jun 11, 2026
Equity, option to acquire, security to be acquired, signed · Form D
$0
of $7.4M
Jun 11, 2026Equity, option to acquire, security to be acquired
Signed as Chief Executive Officer
$0
$7.4M
- Jun 11, 2026
Equity, option to acquire, security to be acquired, signed · Form D
$114.7M
of $186.4M
Jun 11, 2026Equity, option to acquire, security to be acquired
Signed as Chief Executive Officer
$114.7M
$186.4M
Network
At Quince Therapeutics
6 peopleExecutive Officer, Director
Executive Officer
Executive Officer
Director
Director
Director